HC Government Realty Trust Develops National Accounts Team with the Appointment of James P. Manouse, who Joins as the Company’s new Senior Director of National Accounts

SARASOTA, Fla., May 21, 2018 (GLOBE NEWSWIRE) -- HC Government Realty Trust, Inc. (“HCGRT” or the “Company”) today announced the appointment of James P. Manouse, as its new Senior Director of National Accounts. Mr. Manouse will be responsible for developing strategic partnerships with broker-dealers and growing the sales and distribution platform for HCGRT nationally.

Mr. Manouse brings more than 20 years of capital markets experience to his role at HCGRT. Prior to joining the company, he served as the Chief Distribution Officer for Lodging Opportunity Fund REIT where he was responsible for developing their product distribution, national marketing strategy and the development and management of their product sales team.

Mr. Manouse earned a bachelor’s degree from Binghamton University. He serves on the Government Affairs/Political Advocacy committee for the Investment Program Association and on the Regulatory Affairs committee for the Alternative and Direct Investment Securities Association. Mr. Manouse holds FINRA Series 7, 24 and 66 licenses.

About HC Government Realty Trust, Inc.
HC Government Realty Trust, Inc. is a Maryland REIT that is publicly offered through Regulation A+ and specializes in the acquisition and management of single tenant built/refit-to-suit federal government leased properties in secondary and smaller markets. The Company’s current portfolio consists of U.S. government tenant agencies such as the DEA, FBI, SSA, ICE, CIS, and US Customs & Border Protection. For more information, please visit our corporate website at www.hcgovtrust.com.

About this Press Release
This press release is neither an offer to sell nor a solicitation of an offer to buy any securities of the Company, including without limitation the common stock. Any such offer is made exclusively through the Company’s final offering circular dated November 7, 2016, as the same may be amended or supplemented (the “Final Offering Circular”). The Final Offering Circular is available at: https://www.sec.gov/Archives/edgar/data/1670010/000165495417011724/hcgr_253g2.htm

Forward-Looking Statements
We make statements in this press release that are considered “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), which are usually identified by the use of words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “will,” and variations of such words or similar expressions. We intend for these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and are including this statement in this press release for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control.  For further discussion of the factors that could affect outcomes, please refer to the risk factors set forth in the “Risk Factors” section of the Final Offering Circular. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact:                                                                        
Email: ir@hcgovtrust.com                                                           
Tel: 941-955-7900